Latest News & Updates

Breaking News

  • 1 hour ago

  • Simantini Singh Deo

RenovoRx Strengthens Its Scientific Advisory Board With The Appointment Of Pancreatic Cancer Expert Dr. Timothy Donahue
Breaking News
Novo Nordisk Reaches Agreement With U.S. Administration To Expand Access To GLP-1 Medicines At Lower Cost For Americans

Simantini Singh Deo

Other trending news you may like to read

RenovoRx Strengthens Its Scientific Advisory Board With The Appointment Of Pancreatic Cancer Expert Dr. Timothy Donahue

RenovoRx appoints UCLA pancreatic surgery expert Dr. Timothy Donahue to its Scientific Advisory Board to support advancements in targeted cancer therapies.

Simantini Singh Deo

Pharma Now

Novo Nordisk Reaches Agreement With U.S. Administration To Expand Access To GLP-1 Medicines At Lower Cost For Americans

Novo Nordisk partners with the U.S. Administration to cut semaglutide drug prices and expand Medicare coverage for obesity treatments from 2026.

Simantini Singh Deo

Pharma Now

Nasus Pharma Secures Health Canada Approval To Start Phase 2 Clinical Trial Of NS002 Intranasal Epinephrine Powder

Nasus Pharma receives Health Canada clearance to begin Phase 2 trial of NS002, its intranasal epinephrine powder for treating anaphylaxis.

Simantini Singh Deo

Pharma Now

Coherus Oncology Appoints Arvind Sood As Chief Strategy And Corporate Affairs Officer To Strengthen Strategic And External Relations

Coherus Oncology appoints Arvind Sood as Chief Strategy and Corporate Affairs Officer to drive strategic growth and investor engagement.

Simantini Singh Deo

Pharma Now